Skip to Main Content

Paper Details

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients.
Mol Syst Biol
23
2021
NAFLD, Nonalcoholic fatty liver disease, alanine, alanine aminotransferase, aspartate, aspartate aminotransferase, creatinine, excess fat accumulation, hepatic steatosis, human, inflammation, nonalcoholic fatty liver disease, patients, uric acid
Author NameAffiliation
Muhammad ArifKTH - Royal Institute of Technology
Jochen M SchwenkKTH - Royal Institute of Technology
Jochen M SchwenkKTH - Royal Institute of Technology
Cheng ZhangKTH - Royal Institute of Technology
Cheng ZhangSchool of Pharmaceutical Sciences, Zhengzhou University
Jens NielsenChalmers University of Technology
Jens NielsenChalmers University of Technology
Mathias Uhl??nKTH - Royal Institute of Technology
Mathias Uhl??nKTH - Royal Institute of Technology
Adil MardinogluKTH - Royal Institute of Technology
Adil MardinogluKing's College London
Adil MardinogluKTH - Royal Institute of Technology
Adil MardinogluKing's College London
  • 1 - 13

Datasets

Release 1.2